MBQ-167 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Cdc42 inhibitor, PAK inhibitor, Rac and Cdc42 inhibitor, Rac inhibitor, Rac/Cdc42 inhibitor

Filter by location:

Beverly Hills, California1 trial

A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

Precision Next Gen Oncology & Research Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.